- Published
- 19 November 2024
- Journal article
Age and outcomes in people with type 2 diabetes admitted to hospital with COVID-19: A cohort study
- Authors
- Source
- Diabetic Medicine
Full text
Abstract
Type 2 diabetes has been associated with an increased risk of COVID-19 severity and mortality. The incidence of young onset (aged <50 years) T2D (YOT2D) has increased in many countries over the past 30 years, particularly in ethnic minority groups. Accumulating evidence confirms that individuals with YOT2D have greater risks of developing micro- and macrovascular complication. The reasons for poorer outcomes in YOT2D are not known but associated risk factors include female sex, obesity, low birthweight, family history of T2D and non-white ethnicity. In view of the high-risk phenotype, YOT2D may have worse outcomes following COVID-19.
The aim of this study was, therefore, to assess outcomes, by age on admission to hospital, in two cohorts with T2D: young (<50 years) and older (≥50 years).
Rights
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/
Cite as
Ni'Man, M., Ruan, Y., Davies, J., Harris, S., Nagi, D., Narendran, P., Field, B., Idris, I., Patel, D., Rea, R., Ryder, R., Wild, S., Várnai, K., Wilmot, E. & Khunti, K. 2024, 'Age and outcomes in people with type 2 diabetes admitted to hospital with COVID-19: A cohort study', Diabetic Medicine, article no: e15481. https://doi.org/10.1111/dme.15481